Source:http://linkedlifedata.com/resource/pubmed/id/11859089
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
2002-4-15
|
pubmed:abstractText |
The pre-hairpin intermediate of gp41 from the human immunodeficiency virus (HIV) is the target for two classes of fusion inhibitors that bind to the C-terminal region or the trimeric coiled-coil of N-terminal helices, thereby preventing formation of the fusogenic trimer of hairpins. Using rational design, two 36-residue peptides, N36(Mut(e,g)) and N36(Mut(a,d)), were derived from the parent N36 peptide comprising the N-terminal helix of the gp41 ectodomain (residues 546-581 of HIV-1 envelope), characterized by analytical ultracentrifugation and CD, and assessed for their ability to inhibit HIV fusion using a quantitative vaccinia virus-based fusion assay. N36(Mut(e,g)) contains nine amino acid substitutions designed to disrupt interactions with the C-terminal region of gp41 while preserving contacts governing the formation of the trimeric coiled-coil. N36(Mut(a,d)) contains nine substitutions designed to block formation of the trimeric coiled-coil but retains residues that interact with the C-terminal region of gp41. N36(Mut(a,d)) is monomeric, is largely random coil, does not interact with the C34 peptide derived from the C-terminal region of gp41 (residues 628-661), and does not inhibit fusion. The trimeric coiled-coil structure is therefore a prerequisite for interaction with the C-terminal region of gp41. N36(Mut(e,g)) forms a monodisperse, helical trimer in solution, does not interact with C34, and yet inhibits fusion about 50-fold more effectively than the parent N36 peptide (IC(50) approximately 308 nm versus approximately 16 microm). These results indicate that N36(Mut(e,g)) acts by disrupting the homotrimeric coiled-coil of N-terminal helices in the pre-hairpin intermediate to form heterotrimers. Thus N36(Mut(e,g)) represents a novel third class of gp41-targeted HIV fusion inhibitor. A quantitative model describing the interaction of N36(Mut(e,g)) with the pre-hairpin intermediate is presented.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14238-45
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11859089-Amino Acid Sequence,
pubmed-meshheading:11859089-Anti-HIV Agents,
pubmed-meshheading:11859089-Circular Dichroism,
pubmed-meshheading:11859089-Dose-Response Relationship, Drug,
pubmed-meshheading:11859089-Drug Design,
pubmed-meshheading:11859089-HIV,
pubmed-meshheading:11859089-HIV Envelope Protein gp41,
pubmed-meshheading:11859089-Models, Biological,
pubmed-meshheading:11859089-Molecular Sequence Data,
pubmed-meshheading:11859089-Peptides,
pubmed-meshheading:11859089-Protein Conformation,
pubmed-meshheading:11859089-Protein Structure, Tertiary,
pubmed-meshheading:11859089-Ultracentrifugation
|
pubmed:year |
2002
|
pubmed:articleTitle |
Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41.
|
pubmed:affiliation |
Laboratories of Bioorganic Chemistry, Chemical Physics, and Molecular Biology, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA. caroleb@intra.niddk.nih.gov
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|